BioLineRx (BLRX) Gross Margin (2024 - 2025)
Historic Gross Margin for BioLineRx (BLRX) over the last 2 years, with Q3 2025 value amounting to 80.33%.
- BioLineRx's Gross Margin fell 30400.0% to 80.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 50.69%, marking a year-over-year decrease of 262700.0%. This contributed to the annual value of 67.99% for FY2024, which is 449100.0% up from last year.
- BioLineRx's Gross Margin amounted to 80.33% in Q3 2025, which was down 30400.0% from 76.32% recorded in Q2 2025.
- In the past 5 years, BioLineRx's Gross Margin registered a high of 86.67% during Q1 2025, and its lowest value of 48.17% during Q4 2024.